Indonesia Clinical Laboratory Services Market, By Service Type (Routine Testing Services, Esoteric Services, and Anatomic Pathology Services), Specialty (Clinical Chemistry Testing, Hematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing and Genetic Testing), Provider (Hospital-Based Laboratories, Independent and Reference Laboratories, Clinical-Based Laboratories, and Nursing and Physician Office-Based Laboratories), Application (Bioanalytical and Lab Chemistry Services, Drug Development Related Services, Drug Discovery Related Services, Toxicology Testing Services, Cell, and Gene Therapy Related Services, Preclinical and Clinical Trial Related Services, and Other Clinical Laboratory Services), Country (Indonesia) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Indonesia Clinical Laboratory Services Market
Indonesia clinical laboratory services market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the Indonesia clinical laboratory services market is growing with a CAGR of 5.5% in the forecast period of 2021 to 2028 and is expected to reach USD 2,482.31 million by 2028 from USD 1,622.47 million in 2020. The rising preference for preventive health check-ups and the rising prevalence of chronic diseases are the major drivers that propelled the market's demand in the forecast period.
Clinical laboratories are an important part of the healthcare sector. Most diagnostic tests, starting from the blood test to the genetic analysis, are conducted in these clinical laboratories to detect diseases. Clinical laboratories offer data and resources that optimize the required distribution in the healthcare system, such as diagnostics and test results. This maintains and provides reliable and correct test results that enable doctors to make appropriate clinical and diagnostic decisions across various levels of health care services.
The increasing adoption of digital pathology has further propelled the demand for clinical laboratory services. The high prevalence of infectious diseases across Indonesia and the increasing awareness of early and accurate diagnosis are likely to fuel the growth of the clinical laboratory services market. Moreover, inadequate reimbursement policies act as a challenge for the market. The strategic initiatives by market players and rising preventive health check-ups act as an opportunity for the market's growth. However, lack of certified and skilled professionals and stringent regulatory policies act as a restraint for its growth in the market.
The Indonesia clinical laboratory services market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
Indonesia Clinical Laboratory Services Market Scope and Market Size
The Indonesia clinical laboratory services market is segmented based on service type, specialty, provider, and application. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of service type, the Indonesia clinical laboratory services market is segmented into routine testing services, esoteric services, and anatomic pathology services. In 2021, the routine testing services segment is expected to dominate the market due to the rising prevalence of chronic diseases such as HIV.
- On the basis of specialty, the Indonesia clinical laboratory services market is segmented into clinical chemistry testing, microbiology testing, haematology testing, genetic testing, drugs of abuse testing, and immunology testing. In 2021, the clinical chemistry testing segment is expected to dominate the market due to the rise in research activities to understand the pathophysiology of a particular disease process.
- On the basis of provider, the Indonesia clinical laboratory services market is segmented into independent and reference laboratories, hospital-based laboratories, and nursing and physician office-based laboratories. In 2021, the hospital-based laboratories segment is expected to dominate the market due to an increase in emergency cases of injury, which leads to more patients and high test demands.
- On the basis of application, the Indonesia clinical laboratory services market is segmented into drug discovery related services, drug development related services, bioanalytical and lab chemistry services, toxicology testing services, cell and gene therapy related services, preclinical and clinical trial related services, and other clinical laboratory services. In 2021, the bioanalytical and lab chemistry services segment is expected to dominate the market due to rise in the advanced clinical diagnostic methods.
Growing Adoption of Digital Pathology Platforms and Increasing Awareness of Early and Accurate Diagnosis in the Clinical Laboratory Services is Creating New Opportunities for Players in the Indonesia Clinical Laboratory Services Market
Indonesia clinical laboratory services market also provides you with a detailed market analysis of market sales, the impact of advancement in the Indonesia clinical laboratory services market, and changes in regulatory scenarios with their support for the Indonesia clinical laboratory services market. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Indonesia Clinical Laboratory Services Market Share Analysis
Indonesia clinical laboratory services market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Indonesia clinical laboratory services market.
The major players covered in the Indonesia clinical laboratory services report are Eurofins Scientific, Siemens Healthcare GmbH, Abbott, Charles River Laboratories, Laboratory Corporation of America Holdings, Parahita Diagnostic Center, CITO Clinical Laboratory, Brianet, SGS SA, Syneos Health, Prodia, Keralty, among others and domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies, which also accelerate the Indonesia clinical laboratory services market.
For instances,
- In June 2021, Charles River announced that it had completed the previously announced acquisition of Vigene Biosciences, Inc. for USD 292.5 million in cash, subject to customary closing adjustments. The addition of Vigene Biosciences’ extensive gene therapy capabilities will enhance Charles River’s position as a premier scientific partner for cell and gene therapies
- In December 2020, the CITO Clinical Laboratory was designated by the Ministry of Health (Kemenkes) to be one of the laboratories for examining the coronavirus. This helped to be recognized across the region and thereby sustain footprints in the market
SKU-